Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
4.530
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about COMPASS Pathways Plc - American Depository Shares
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
29
30
Next >
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
June 24, 2022
GAINERS: Allied (OTC:ALID) shares closed up 29.44% at $0.56
Via
Benzinga
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
June 23, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 6.63% at $0.71
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 22, 2022
June 22, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 4.17% at $3.50
Via
Benzinga
US Senate Moves Forward On Gun Reform: 3 Stocks That Could Benefit As A Result
June 22, 2022
Tuesday night, the U.S. Senate finally cleared a procedural vote to move forward with gun control legislation. The action comes after weeks of negotiations.
Via
Benzinga
Revive Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
June 21, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.43% at $0.31
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 17, 2022
June 17, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.69% at $0.67
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 16, 2022
June 16, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.08% at $10.05 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 15, 2022
June 15, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 9.11% at $0.62
Via
Benzinga
World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health
June 15, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a...
Via
FinancialNewsMedia
Psychedelic Stock Gainers And Losers From June 14, 2022
June 14, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 9.90% at $9.44
Via
Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
June 13, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 1.06% at $0.81 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 10, 2022
June 10, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.67
Via
Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
June 09, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.55% at $0.13
Via
Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
June 08, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 7.70% at $0.78
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
June 07, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 9.47% at $0.72
Via
Benzinga
Rising Cases Of Mental Health Disorders of Stress, Anxiety & Addiction Fueling Need for Central Nervous System Therapeutics
June 07, 2022
Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – The global Central Nervous System (CNS) treatments and its market revenues had been steadily growing pre-pandemic and are still...
Via
FinancialNewsMedia
Exposures
COVID-19
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
June 06, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.55% at $0.36
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 3, 2022
June 03, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.88% at $0.35
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
June 02, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 9.50% at $0.75
Via
Benzinga
These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry
June 02, 2022
In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its...
Via
Benzinga
ATAI Life Sciences, Intelgenx Technologies Among Top Psychedelic Movers Of Today
June 01, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 7.05% at $0.91
Via
Benzinga
Psychedelic Stock Gainers And Losers From May 31, 2022
May 31, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 8.54% at $0.36
Via
Benzinga
Psychedelic Compounds-Based Stocks Continue To Decline
May 29, 2022
Our index tracks 6 of the largest clinical-stage startups, which have an average market capitalization of $65.5M and an average stock price of $0.69/share.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From May 26, 2022
May 26, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.06% at $0.34
Via
Benzinga
TripAdvisor, Seelos Therapeutics Among Top Psychedelic Movers Of Today
May 25, 2022
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 6.06% at $23.45
Via
Benzinga
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company
May 24, 2022
Medical Psychedelics have made it into Davos, just in time for the World Economic Forum.
Via
Benzinga
Psychedelic Stock Gainers And Losers From May 24, 2022
May 24, 2022
GAINERS: LOSERS: Cybin (AMEX:CYBN) shares closed down 9.99% at $0.61
Via
Benzinga
Cybin, Small Pharma Among Top Psychedelic Movers Of Today
May 23, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68
Via
Benzinga
Christian Angermayer Bullish On Psychedelic Sector And Life Extension Technology
May 23, 2022
In this week’s Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer.
Via
Benzinga
Can Psilocybin Help With Treatment-Resistant Depression? COMPASS Pathways Study Shows Promising Results
May 23, 2022
COMPASS Pathways plc (NASDAQ: CMPS), a mental health care company, presented positive data from the randomized, controlled, double-blind study of psilocybin therapy, at the American Psychiatric...
Via
Benzinga
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.